AUROBINDO PHARMA LTD.
? ?
Aurobindo is a Young Indian Pharmaceutical company born in Year 1986. Aurobindo's mission is to become the most valued Pharma partner for the World Pharma fraternity by continuously researching, developing and manufacturing a wide range of pharmaceutical products complying to the highest regulatory standards. A well integrated pharma company with focus on formulations. Vertically Integrated pharmaceutical company with huge capacity giving economies of scale. In house R&D for rapid filing of Patents, ANDAs & DMFs Global Regulatory approved manufacturing base Global presence with manufacturing infrastructure, strategic alliances, subsidiaries and joint ventures. Exporting to 125+ countries with 70%+ of revenues from international operations Well spread global marketing network through 40 subsidiaries Employee base of 7800+ including 700+ scientists Strong foundation for sustained organic growth
? ?
? ? ?
? ? ? ?
AUROBINDO PHARMA LTD.
?
INFRASTRUCTURE ? Over 5 million sq meter area spread for state of the art manufacturing facilities. ? Facilities approved by USFDA, UK-MHRA, FEMIA,INFARMED, PT, MCC South Africa, Anvisa-Brazil and many other regulated and semi-regulated drug Minsitry. R&D
?
?
Aurobindo's R & D strengths lie in developing intellectual property in non-infringing processes and resolving complex chemistry challenge
?
Product Portfolio ? Therapeutic Segments comprise of Antibiotics, ARVs, CNS, Anti Depressants, Anti Alzheimer, Gastroenterological. ? Over 250 formulations including immediate release, control release, mouth disintegration tablets, capsules, liquids and Lyophilized Sterile Inj. ? Huge Product Portfolio of EU CTD Dossiers for Out-Licensing Operations. Marketing ? Global Marketing Infrastructure through subsidiaries, distribution, joint ventures. ? Exports to over 100 countries with significant strategic marketing presence in USA, Europe, Latin America, CIS, SEAN. ? Subsidiaries across the Globe. Milestone ? Year 2010-11 : The company is in its celebration of Silver Jubilee Year of Operations and CROSSED BILLION DOLLARS mark of consolidated total operating income. ? 57.3% - Formulation Business (Up By 30% from the previous Year) ? 64% Business from International Operations. ? 227 Dossier Filings in Europe (Year 2010-11), cumulative filings 991 ? Amongst top 5 Pharma companies in India interms of exports and revenue.
?
?
doc_654829441.ppt
? ?
Aurobindo is a Young Indian Pharmaceutical company born in Year 1986. Aurobindo's mission is to become the most valued Pharma partner for the World Pharma fraternity by continuously researching, developing and manufacturing a wide range of pharmaceutical products complying to the highest regulatory standards. A well integrated pharma company with focus on formulations. Vertically Integrated pharmaceutical company with huge capacity giving economies of scale. In house R&D for rapid filing of Patents, ANDAs & DMFs Global Regulatory approved manufacturing base Global presence with manufacturing infrastructure, strategic alliances, subsidiaries and joint ventures. Exporting to 125+ countries with 70%+ of revenues from international operations Well spread global marketing network through 40 subsidiaries Employee base of 7800+ including 700+ scientists Strong foundation for sustained organic growth
? ?
? ? ?
? ? ? ?
AUROBINDO PHARMA LTD.
?
INFRASTRUCTURE ? Over 5 million sq meter area spread for state of the art manufacturing facilities. ? Facilities approved by USFDA, UK-MHRA, FEMIA,INFARMED, PT, MCC South Africa, Anvisa-Brazil and many other regulated and semi-regulated drug Minsitry. R&D
?
?
Aurobindo's R & D strengths lie in developing intellectual property in non-infringing processes and resolving complex chemistry challenge
?
Product Portfolio ? Therapeutic Segments comprise of Antibiotics, ARVs, CNS, Anti Depressants, Anti Alzheimer, Gastroenterological. ? Over 250 formulations including immediate release, control release, mouth disintegration tablets, capsules, liquids and Lyophilized Sterile Inj. ? Huge Product Portfolio of EU CTD Dossiers for Out-Licensing Operations. Marketing ? Global Marketing Infrastructure through subsidiaries, distribution, joint ventures. ? Exports to over 100 countries with significant strategic marketing presence in USA, Europe, Latin America, CIS, SEAN. ? Subsidiaries across the Globe. Milestone ? Year 2010-11 : The company is in its celebration of Silver Jubilee Year of Operations and CROSSED BILLION DOLLARS mark of consolidated total operating income. ? 57.3% - Formulation Business (Up By 30% from the previous Year) ? 64% Business from International Operations. ? 227 Dossier Filings in Europe (Year 2010-11), cumulative filings 991 ? Amongst top 5 Pharma companies in India interms of exports and revenue.
?
?
doc_654829441.ppt